Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 17 of 17 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company BE Pharmaceuticals USA Inc. | Activity: Sales and Operations | Company Description BE Pharmaceuticals USA is the US office for Biological E Ltd., a vaccine manufacturing company headquartered in India. | Location Cary |
| |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill |
| |
Company Clarus Biologics Inc. | Activity: Research and Development | Company Description Clarus Biologics is developing innovative vaccine and immunotherapeutic products using a novel and proprietary self-amplifying mRNA delivery and viral particle technology platform. Its first innovation is a vaccine VLP that enhances the effectiveness, efficiency and availability of vaccines. | Location Chapel Hill |
| |
Company DuraVax Inc. | Activity: Research and Development | Company Description DuraVax is developing thermo-stable liquid formulations for RNA pharmaceuticals. | Location Wilmington |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh |
| |
Company Huvepharma Inc. | Activity: Production and Manufacturing | Company Description Huvepharma manufactures Coccidiosis vaccines for in ovo and post-hatch vaccination of poultry. | Location Maxton |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Jurata Thin Film Inc. | Activity: Research and Development | Company Description Jurata Thin Film is developing an oral, thin film vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes inexpensively, without refrigeration. | Location Chapel Hill |
| |
Company Pharmgate Animal Health LLC | Activity: Research and Development | Company Description Pharmgate Animal Health develops and markets medicines and vaccines for the control of disease in livestock and poultry in North America. | Location Wilmington |
| |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte |
| |
Company Takeda Vaccines Inc. | Activity: Sales and Operations | Company Description Takeda's Vaccine Business Unit develops vaccines, including norovirus, dengue and seasonal influenza candidate vaccines. | Location Morrisville |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary |